MAX HEALTHCARE INSTITUTE LIMITED Financials Max Healthcare Institute Limited
Equities
MAXHEALTH
INE027H01010
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 802.4 INR | -0.06% |
|
+3.94% | +16.70% |
| 23/04 | Max Healthcare Institute Acquires Additional 3% Stake in Sandhya Hydro Power | MT |
| 23/04 | AppLovin Corporation : The future of app marketplace? |  |
Valuation
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,99,033 | 3,36,359 | 4,28,177 | 7,79,863 | - | - |
| Enterprise Value (EV) 1 | 2,03,285 | 3,40,500 | 4,20,386 | 7,66,260 | 7,66,280 | 7,56,025 |
| P/E ratio | -130 x | 55.6 x | 38.8 x | 59.5 x | 49.9 x | 39.7 x |
| Yield | - | - | 0.23% | 0.16% | 0.18% | 0.23% |
| Capitalization / Revenue | 7.95 x | 8.56 x | 9.38 x | 11.4 x | 9.34 x | 7.47 x |
| EV / Revenue | 8.12 x | 8.66 x | 9.21 x | 11.2 x | 9.17 x | 7.24 x |
| EV / EBITDA | 50.3 x | 36.1 x | 33.9 x | 40.9 x | 33.6 x | 26.6 x |
| EV / FCF | - | 182 x | 48.1 x | 311 x | 116 x | 54.3 x |
| FCF Yield | - | 0.55% | 2.08% | 0.32% | 0.86% | 1.84% |
| Price to Book | 3.53 x | 5.35 x | 5.78 x | 8.53 x | 7.36 x | 6.27 x |
| Nbr of stocks (in thousands) | 9,65,945 | 9,69,613 | 9,70,923 | 9,71,912 | - | - |
| Reference price 2 | 206.0 | 346.9 | 441.0 | 802.4 | 802.4 | 802.4 |
| Announcement Date | 28/05/21 | 25/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 25,047 | 39,315 | 45,626 | 68,521 | 83,522 | 1,04,461 |
| EBITDA 1 | 4,039 | 9,426 | 12,405 | 18,752 | 22,818 | 28,465 |
| EBIT 1 | 2,298 | 7,214 | 10,083 | 16,167 | 19,577 | 24,611 |
| Operating Margin | 9.17% | 18.35% | 22.1% | 23.59% | 23.44% | 23.56% |
| Earnings before Tax (EBT) 1 | -686.5 | 7,389 | 10,637 | 16,248 | 19,529 | 24,601 |
| Net income 1 | -1,145 | 6,050 | 11,035 | 13,225 | 15,957 | 20,246 |
| Net margin | -4.57% | 15.39% | 24.19% | 19.3% | 19.1% | 19.38% |
| EPS 2 | -1.590 | 6.240 | 11.36 | 13.50 | 16.10 | 20.19 |
| Free Cash Flow 1 | - | 1,872 | 8,736 | 2,466 | 6,625 | 13,914 |
| FCF margin | - | 4.76% | 19.15% | 3.6% | 7.93% | 13.32% |
| FCF Conversion (EBITDA) | - | 19.86% | 70.42% | 13.15% | 29.03% | 48.88% |
| FCF Conversion (Net income) | - | 30.94% | 79.16% | 18.64% | 41.52% | 68.73% |
| Dividend per Share 2 | - | - | 1.000 | 1.312 | 1.475 | 1.829 |
| Announcement Date | 28/05/21 | 25/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,956 | 8,019 | 10,002 | 10,183 | 9,742 | 9,388 | 10,003 | 11,371 | 11,412 | 12,145 | 12,850 | 16,799 | 16,892 | 17,895 | - |
| EBITDA 1 | 1,601 | 1,681 | 3,600 | 3,620 | 2,458 | 2,103 | 2,644 | 3,188 | 3,134 | 3,403 | 3,374 | 4,581 | 4,673 | 4,990 | - |
| EBIT 1 | 1,117 | 1,205 | - | - | - | - | 2,072 | 2,612 | 2,564 | 2,800 | 2,816 | 3,775 | 3,792 | 4,132 | - |
| Operating Margin | 14.04% | 15.03% | - | - | - | - | 20.72% | 22.97% | 22.47% | 23.05% | 21.91% | 22.47% | 22.45% | 23.09% | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 2,164 | 2,652 | 2,814 | 3,007 | 3,035 | 3,849 | 4,164 | 4,314 | - |
| Net income 1 | - | - | - | - | - | - | 1,728 | 4,574 | 2,224 | 2,509 | 2,401 | 3,160 | 3,456 | 3,520 | - |
| Net margin | - | - | - | - | - | - | 17.28% | 40.22% | 19.49% | 20.66% | 18.68% | 18.81% | 20.46% | 19.67% | - |
| EPS 2 | 1.000 | 0.7500 | - | 1.490 | 1.960 | 1.270 | 1.780 | 4.710 | 2.290 | 2.580 | 2.460 | 3.240 | 3.397 | 3.525 | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | 1.000 | - | - | - | - | - |
| Announcement Date | 06/02/21 | 28/05/21 | 10/08/21 | 12/11/21 | 12/02/22 | 25/05/22 | 10/08/22 | 01/11/22 | 02/02/23 | 16/05/23 | 07/08/23 | - | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 4,252 | 4,141 | - | - | - | - |
| Net Cash position 1 | - | - | 7,791 | 13,603 | 13,582 | 23,837 |
| Leverage (Debt/EBITDA) | 1.053 x | 0.4393 x | - | - | - | - |
| Free Cash Flow 1 | - | 1,872 | 8,736 | 2,466 | 6,625 | 13,914 |
| ROE (net income / shareholders' equity) | -3.36% | 10.3% | 16.1% | 15.1% | 15.5% | 16.7% |
| ROA (Net income/ Total Assets) | -2.2% | 6.91% | 11.4% | 11.7% | 12.3% | 13.5% |
| Assets 1 | 52,102 | 87,600 | 96,455 | 1,13,463 | 1,29,470 | 1,50,202 |
| Book Value Per Share 2 | 58.40 | 64.80 | 76.30 | 94.10 | 109.0 | 128.0 |
| Cash Flow per Share 2 | - | 7.720 | 12.50 | 12.60 | 17.00 | 20.00 |
| Capex 1 | 1,184 | 5,613 | 3,356 | 10,631 | 15,107 | 12,093 |
| Capex / Sales | 4.73% | 14.28% | 7.36% | 15.51% | 18.09% | 11.58% |
| Announcement Date | 28/05/21 | 25/05/22 | 16/05/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
802.4
INR
Average target price
844.2
INR
Spread / Average Target
+5.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.70% | 9.35B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- MAXHEALTH Stock
- Financials Max Healthcare Institute Limited
